GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 54,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
GE Healthcare Technologies Inc (GEHC)'in P/E oranı nedir?
GE Healthcare Technologies Inc 'in P/E oranı 18.429 'dir
GE Healthcare Technologies Inc 'in CEO'su kimdir?
Mr. Peter Arduini 2022 'den beri şirketle birlikte olan GE Healthcare Technologies Inc 'in President 'ıdır.
GEHC hissesinin fiyat performansı nasıl?
GEHC 'in mevcut fiyatı $72.36 'dir, son işlem günde 1.97% arttırılmış etti.
GE Healthcare Technologies Inc için ana iş temaları veya sektörler nelerdir?
GE Healthcare Technologies Inc Health Care endüstrisine ait ve sektör Health Care 'dir
GE Healthcare Technologies Inc 'in piyasa değerlemesi nedir?
GE Healthcare Technologies Inc 'in mevcut piyasa değerlemesi $32.9B 'dir
GE Healthcare Technologies Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 23 analist GE Healthcare Technologies Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 9 güçlü al, 11 al, 7 tut, 0 sat ve 9 güçlü sat içermektedir